As there is evidence suggesting that the NMDA and A2A receptors interact, at least within the striatum [14], the therapeutic potential of the combined administration of A2A and NR2B antagonists was assessed in the unilateral 6-OHDA-lesioned rat PD model [15]. The gene discussed is GRIN2B; the disease is Parkinson disease.